169 related articles for article (PubMed ID: 33910525)
1. Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels?
Lee J; Yang SW; Jin L; Lee CL; Lee JY; Shin JH; Lim JS; Song KH
BMC Cancer; 2021 Apr; 21(1):472. PubMed ID: 33910525
[TBL] [Abstract][Full Text] [Related]
2. [Value of prostate-specific antigen density and transitional-zone prostate-specific antigen density in the diagnosis of prostate cancer].
Martínez Jabaloyas JM; García Morata F; Villamón Fort R; Pastor Hernández F; Gil Salom M; García Sisamón F
Actas Urol Esp; 2003 Jun; 27(6):442-9. PubMed ID: 12918151
[TBL] [Abstract][Full Text] [Related]
3. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL.
Castro HAS; Iared W; Santos JEM; Solha RS; Shigueoka DC; Ajzen SA
Int Braz J Urol; 2018; 44(4):709-716. PubMed ID: 29697929
[TBL] [Abstract][Full Text] [Related]
4. Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml
Wang C; Wang YY; Wang SY; Ding JX; Ding M; Ruan Y; Wang XH; Jing YF; Han BM; Xia SJ; Jiang CY; Zhao FJ
Asian J Androl; 2021; 23(4):415-420. PubMed ID: 33473011
[TBL] [Abstract][Full Text] [Related]
5. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
[TBL] [Abstract][Full Text] [Related]
6. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
7. The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men.
Teoh JY; Yuen SK; Tsu JH; Wong CK; Ho BS; Ng AT; Ma WK; Ho KL; Yiu MK
Asian J Androl; 2017; 19(1):113-116. PubMed ID: 26620456
[TBL] [Abstract][Full Text] [Related]
8. Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma.
Kim JJ; Suh YS; Kim TH; Jeon SS; Lee HM; Choi HY; Kim S; Lee KS
Sci Rep; 2019 Jan; 9(1):770. PubMed ID: 30683879
[TBL] [Abstract][Full Text] [Related]
9. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
[TBL] [Abstract][Full Text] [Related]
10. [Retrospective evaluation of PSA density for selection of biopsy candidates with prostate specific antigen in the gray zone].
Tochigi T; Kawamura S; Numahata K; Tokuyama S; Kuwahara M; Horaguchi T; Satou S
Nihon Hinyokika Gakkai Zasshi; 2001 Sep; 92(6):609-14. PubMed ID: 11593702
[TBL] [Abstract][Full Text] [Related]
11. Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.
Sheikh M; Al-Saeed O; Kehinde EO; Sinan T; Anim JT; Ali Y
Int Urol Nephrol; 2005; 37(4):721-6. PubMed ID: 16362587
[TBL] [Abstract][Full Text] [Related]
12. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.
Aksoy Y; Oral A; Aksoy H; Demirel A; Akcay F
Ann Clin Lab Sci; 2003; 33(3):320-3. PubMed ID: 12956448
[TBL] [Abstract][Full Text] [Related]
13. Utility of the transition zone index for identification of prostate cancer in Chinese men with intermediate PSA levels.
Qi TY; Chen YQ; Jiang J; Zhu YK; Yao XH; Wang XJ
Int Urol Nephrol; 2012 Jun; 44(3):807-15. PubMed ID: 22311386
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Cutoff Point Prostate Specific Antigen (PSA) and Prostate Specific Antigen Density (PSAD) in Patients with Suspected Prostate Cancer.
Daryanto B; Trianto R; Seputra KP; Purnomo AF
Med Arch; 2024; 78(1):12-15. PubMed ID: 38481588
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.
MacAskill F; Lee SM; Eldred-Evans D; Wulaningsih W; Popert R; Wolfe K; Van Hemelrijck M; Rottenberg G; Liyanage SH; Acher P
Int Urol Nephrol; 2017 Aug; 49(8):1335-1342. PubMed ID: 28477301
[TBL] [Abstract][Full Text] [Related]
16. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
Djavan B; Remzi M; Zlotta AR; Ravery V; Hammerer P; Reissigl A; Dobronski P; Kaisary A; Marberger M
Urology; 2002 Oct; 60(4 Suppl 1):4-9. PubMed ID: 12384156
[TBL] [Abstract][Full Text] [Related]
17. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
Bretton PR; Evans WP; Borden JD; Castellanos RD
Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml].
Janane A; Hajji F; Ismail T; Jawad C; Elondo JC; Dakka Y; Ghadouane M; Ameur A; Abbar M; Albouzidi A
Actas Urol Esp; 2012 Feb; 36(2):93-8. PubMed ID: 22188752
[TBL] [Abstract][Full Text] [Related]
19. Transition Zone Prostate-specific Antigen Density Could Better Guide the Rebiopsy Strategy in Men With Prostate Inflammation at Initial Biopsy.
Amini E; Pishgar F; Ayati M; Jamshidian H; Arbab A; Gooshe M; Nowroozi MR
Urology; 2015 Nov; 86(5):985-90. PubMed ID: 26284593
[TBL] [Abstract][Full Text] [Related]
20. The use of prostate specific antigen density to predict clinically significant prostate cancer.
Yusim I; Krenawi M; Mazor E; Novack V; Mabjeesh NJ
Sci Rep; 2020 Nov; 10(1):20015. PubMed ID: 33203873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
